Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.

Source:http://linkedlifedata.com/resource/pubmed/id/8099806

Download in:

View as

General Info

PMID
8099806